Cargando…
Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells
Microvesicle particles (MVP) secreted by a variety of cell types in response to reactive oxygen species (ROS)-generating pro-oxidative stressors have been implicated in modifying the cellular responses including the sensitivity to therapeutic agents. Our previous studies have shown that expression o...
Autores principales: | Chauhan, Shreepa J., Thyagarajan, Anita, Chen, Yanfang, Travers, Jeffrey B., Sahu, Ravi P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696385/ https://www.ncbi.nlm.nih.gov/pubmed/33198218 http://dx.doi.org/10.3390/ijms21228517 |
Ejemplares similares
-
Effects of miRNA-149-5p and Platelet-Activating Factor-Receptor Signaling on the Growth and Targeted Therapy Response on Lung Cancer Cells
por: Chauhan, Shreepa J., et al.
Publicado: (2022) -
Exposure to diesel exhaust particulates and desert sand dust generates microvesicle particles and platelet‐activating factor agonists
por: Thyagarajan, Anita, et al.
Publicado: (2023) -
Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells
por: Thyagarajan, Anita, et al.
Publicado: (2018) -
Topical application of gemcitabine generates microvesicle particles in human and murine skin
por: Thyagarajan, Anita, et al.
Publicado: (2022) -
Radiation therapy produces microvesicle particle release in HaCaT keratinocytes
por: Torralba, Ericson John V., et al.
Publicado: (2023)